Altria Group (MO)
Sells Marlboro cigarettes, oral tobacco, nicotine pouches and NJOY e-vapor products.
$68.65
After hours0.00 (0.00%)
At close$68.65(+0.18%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,277 | 5,024 | 4,717 | 5,277 | 5,344 | 5,106 | 4,519 | 5,290 | 5,251 | 5,079 | 5,428 | 6,111 |
| Cost of revenue | 1,578 | 1,525 | 1,437 | 1,602 | 1,536 | 1,502 | 1,270 | 1,440 | 1,439 | 1,448 | 1,922 | 1,536 |
| Gross profit | 3,699 | 3,499 | 3,280 | 3,675 | 3,808 | 3,604 | 3,249 | 3,850 | 3,812 | 3,631 | 3,506 | 4,575 |
| 610 | 703 | 606 | 1,142 | 656 | 722 | 588 | 619 | 580 | 720 | 550 | 1,439 | |
| Research & development | 0 | 71 | 0 | 0 | 61 | 43 | 0 | 0 | 0 | 0 | 0 | 0 |
| 610 | 703 | 606 | 788 | 656 | 687 | 588 | 619 | 580 | 720 | 550 | 663 | |
| Selling & marketing | 610 | 0 | 606 | 788 | 656 | 0 | 588 | 619 | 580 | 0 | 0 | 0 |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 550 | 663 |
| Other expenses | 0 | −71 | 0 | 354 | −61 | −8 | 0 | 0 | 0 | 0 | 0 | 776 |
| Operating income | 3,089 | 2,796 | 2,674 | 2,533 | 3,152 | 2,882 | 2,661 | 3,231 | 3,232 | 2,911 | 2,956 | 3,136 |
| −181 | −61 | 65 | 2,583 | −126 | −105 | −978 | −113 | −157 | −1,398 | −97 | −207 | |
| Interest expense | 272 | 231 | 254 | 261 | 267 | 255 | 262 | 275 | 278 | 362 | 258 | 295 |
| Other non-operating income | −91 | −330 | −319 | −2,844 | −141 | −237 | 716 | −162 | −121 | 1,036 | −161 | −88 |
| Income before tax | 2,908 | 2,735 | 2,739 | 5,116 | 3,026 | 2,777 | 1,683 | 3,118 | 3,075 | 1,513 | 2,859 | 2,929 |
| Income tax expense | 742 | 675 | 610 | 1,313 | 733 | −262 | 606 | 740 | 700 | 396 | 676 | 631 |
| Net income from continuing operations | 2,166 | 2,060 | 2,129 | 3,803 | 2,293 | 3,039 | 1,077 | 2,378 | 2,375 | 1,117 | 2,183 | 2,298 |
| Net income | 2,166 | 2,060 | 2,129 | 3,803 | 2,293 | 3,039 | 1,077 | 2,378 | 2,375 | 1,117 | 2,183 | 2,298 |
| EPS, basic | $1.22 | $1.16 | $1.21 | $2.21 | $1.34 | $1.80 | $0.63 | $1.41 | $1.41 | $0.66 | $1.30 | $1.37 |
| EPS, diluted | $1.22 | $1.16 | $1.21 | $2.21 | $1.34 | $1.79 | $0.63 | $1.41 | $1.41 | $0.66 | $1.30 | $1.37 |
| Weighted average shares, basic | 1,773 | 1,768 | 1,758 | 1,718 | 1,703 | 1,691 | 1,690 | 1,684 | 1,684 | 1,677 | 1,673 | 1,672 |
| Weighted average shares, diluted | 1,773 | 1,768 | 1,758 | 1,718 | 1,703 | 1,694 | 1,690 | 1,684 | 1,684 | 1,677 | 1,673 | 1,672 |
| EBITDA | 3,260 | 3,204 | 3,058 | 5,451 | 3,367 | 3,192 | 2,016 | 3,464 | 3,423 | 1,929 | 3,173 | 3,224 |
| Depreciation & amortization | 80 | 78 | 65 | 74 | 74 | 73 | 71 | 71 | 70 | 54 | 56 | 0 |
| EBIT | 3,180 | 3,126 | 2,993 | 5,377 | 3,293 | 3,119 | 1,945 | 3,393 | 3,353 | 1,875 | 3,117 | 3,224 |
